Home> Products> mycophenolate mofetil 250 mg

{ "products": [ { "_id": "662b8529e0b5041cf8896919", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Mycophenolate mofetil 250mg", "description": "MYCOPLASM M 250 \nMycophenolate mofetil (250mg)\nMYCOPLASM M 250 is an effective antibiotic used to treat various bacterial infections, including respiratory infections and skin infections. It contains the active ingredient macrolide, which works by stopping the growth of bacteria, thus treating the infection. This medication is particularly useful for patients who are allergic to penicillin. MYCOPLASM M 250 is taken orally and is often prescribed for a course of several days, depending on the severity of the infection. It's important\nFor further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nOrder Now: \n", "price": 365.0, "discountamount": 110.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "growth", "course", "patients", "severity", "medication", "penicillin", "MYCOPLASM M", "several days", "skin infections", "effective antibiotic", "Mycophenolate mofetil", "respiratory infections", "active ingredient macrolide", "various bacterial infections" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 753, "imageuri": "https://productimages.withfloats.com/actual/693130b4e57cafb376214eb5.png", "tileimageuri": "https://productimages.withfloats.com/tile/693130b4e57cafb376214eb5.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-04-26T10:42:49.813Z", "updatedon": "2026-03-12T08:05:22.965Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/mycophenolate-mofetil-250mg/753", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "MYCOPLASM M 250", "category": "Oncology", "tags": [ "bacterial infections", "respiratory infections", "infection.", "Mycophenolate mofetil 250mg" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6661a73687f0960e14a2c739", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "mycophenolate sodium 360 mg", "description": "MYCOPLASM S 360 \nMycophenolate sodium 360 mg is an essential immunosuppressant medication designed to prevent organ transplant rejection, particularly for kidney, heart, and liver transplants. As the sodium salt of mycophenolic acid, it delivers 360 mg of the active moiety per tablet, providing targeted immune suppression to help patients maintain their new organs long-term. This product stands out for its enteric-coated formulation, which enhances gastrointestinal tolerability compared to other forms, making it a preferred choice in post-transplant care regimens.​\n\nUses of Mycophenolate Sodium 360 mg\nMycophenolate sodium 360 mg primarily serves as a prophylactic agent against acute rejection in adult and pediatric patients receiving allogeneic renal, cardiac, or hepatic transplants. It works alongside other immunosuppressants like cyclosporine and corticosteroids to create a balanced regimen that minimizes the risk of graft loss. Clinically, it proves effective in de novo transplant recipients, where starting therapy early post-surgery significantly reduces rejection episodes. Beyond transplants, off-label applications include managing refractory autoimmune conditions such as lupus nephritis or myasthenia gravis, where immune overactivity damages tissues.​\n\nThe drug targets the proliferation of T- and B-lymphocytes, key players in immune responses that can attack transplanted organs. In renal transplant patients, for instance, it helps preserve kidney function by curbing antibody-mediated rejection. Its role extends to maintenance therapy, where consistent dosing sustains immunosuppression without excessive toxicity. Healthcare providers often adjust it based on patient response and trough levels of the active metabolite, mycophenolic acid (MPA), ensuring optimal therapeutic outcomes.​\n\nKey Benefits of Mycophenolate Sodium 360 mg\nMycophenolate sodium 360 mg offers several advantages that make it a cornerstone in transplant medicine. One primary benefit is its selective inhibition of lymphocyte proliferation, sparing other cell types and reducing broad-spectrum immunosuppression risks. This leads to fewer opportunistic infections compared to older agents like azathioprine. The enteric coating minimizes upper GI upset, improving patient compliance—studies show higher adherence rates with this formulation.​\n\nEnhanced Graft Survival: Prolongs organ viability by effectively suppressing cell-mediated and humoral immunity, with clinical data showing reduced biopsy-proven rejection rates.\n\nImproved Tolerability: Lower incidence of nausea and diarrhea due to delayed-release technology, allowing twice-daily dosing without food restrictions.\n\nFlexible Dosing: Equivalent to 720 mg mycophenolate mofetil, but with predictable MPA exposure via enterohepatic recirculation for steady-state efficacy.\n\nPediatric Suitability: Approved for children over 2 years in renal transplants, supporting growth without compromising safety.\n\nCost-Effective Long-Term Option: Balances efficacy and side effect profile, potentially lowering overall healthcare costs from fewer rejections or hospitalizations.​\n\nPatients experience better quality of life, with sustained energy levels and fewer interruptions from acute rejection crises. Its metabolism to MPA via liver glucuronidation ensures reliable pharmacokinetics, even in patients with mild renal impairment.​\n\nSide Effects of Mycophenolate Sodium 360 mg\nWhile highly effective, mycophenolate sodium 360 mg carries risks typical of immunosuppressants, necessitating vigilant monitoring. Common adverse effects stem from its impact on rapidly dividing cells, particularly in the gut and bone marrow.\n\nCommon Side Effects\nGastrointestinal issues like diarrhea, nausea, vomiting, and abdominal pain, affecting up to 30-50% of users.\n\nHeadache, insomnia, and tremor, often mild and transient.\n\nInfections such as urinary tract or respiratory, due to moderated immunity.\n\nHypertension or peripheral edema, manageable with supportive care.\n\nLeukopenia or anemia, requiring periodic blood counts.​\n\nSerious Side Effects\nSevere myelosuppression leading to neutropenia or thrombocytopenia, which can increase infection or bleeding risks.\n\nProgressive multifocal leukoencephalopathy (PML), a rare brain infection linked to JC virus reactivation.\n\nGastrointestinal perforation or bleeding, especially in at-risk patients.\n\nIncreased malignancy risk, including lymphoma or skin cancers, over long-term use.\n\nHypersensitivity reactions like rash or anaphylaxis.​\n\nRegular complete blood counts, viral monitoring (e.g., CMV, BK virus), and skin exams mitigate these risks. Dose reductions or discontinuation may be needed if counts drop significantly.​\n\nMechanism of Action\nMycophenolate sodium 360 mg rapidly hydrolyzes to mycophenolic acid (MPA), a potent, reversible, non-competitive inhibitor of inosine-5'-monophosphate dehydrogenase (IMPDH). This enzyme catalyzes the rate-limiting step in de novo guanine nucleotide synthesis, depleting guanosine nucleotides essential for T- and B-cell DNA replication. Lymphocytes, reliant on this pathway, undergo proliferation arrest, suppressing both cell-mediated immunity and antibody production.​\n\nMPA also hinders glycosylation of adhesion molecules on lymphocytes and monocytes, impeding their migration to graft sites. It reduces nitric oxide production in macrophages without affecting endothelial cells, curbing inflammation. Enterohepatic recirculation of the glucuronide metabolite (MPAG) prolongs MPA exposure, enhancing efficacy. Protein binding to albumin (around 97%) ensures targeted delivery, with clearance primarily renal for the inactive form.​\n\nDosage and Administration Guidelines\nStandard dosing for renal transplant is 720 mg (two 360 mg tablets) twice daily, starting within 72 hours post-surgery. Adjustments occur for hepatic or cardiac transplants, often alongside cyclosporine. Therapeutic drug monitoring of MPA AUC (area under curve) optimizes levels between 30-60 mcg·h/mL. Take on an empty stomach for best absorption, though food has minimal impact due to the coating.​\n\nPrecautions and Warnings\nAvoid in pregnancy (Category D) due to teratogenicity—use contraception and regular pregnancy tests. Contraindicated in active untreated infections. Monitor for GI bleeding in ulcerative colitis patients. Drug interactions with antacids, cholestyramine, or rifampin alter MPA levels. Live vaccines are prohibited.​\n\nConclusion\nMycophenolate sodium 360 mg represents a vital advancement in transplant immunosuppression, offering robust protection against rejection with a favorable benefit-risk profile. Its targeted action on lymphocytes, combined with improved GI tolerance, empowers patients to thrive post-transplant. By integrating it into comprehensive regimens with close monitoring, healthcare teams maximize graft success and patient well-being. Always consult a specialist for personalized guidance to harness its full potential safely.\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nORDER Now: \nhttps://www.sterisonline.com/product/mycoplasm-s-360-133670\n\n\n\n\n\n\n", "price": 767.0, "discountamount": 567.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "dose", "risk", "body", "part", "ORDER", "360mg", "Email", "cells", "dosage", "nausea", "vomiting", "schedule", "headache", "strength", "WhatsApp", "diarrhea", "activity", "rejection", "treatment", "infections", "supplements", "information", "MYCOPLASM S", "sterispharma", "sterisonline", "stomach pain", "blood counts", "immune system", "complications", "liver problems", "liver function", "other medications", "Regular monitoring", "medical conditions", "healthcare provider", "Common side effects", "Serious side effects", "white blood cell count", "potential drug interactions", "optimal therapeutic effects", "combination therapy regimen", "organ transplant recipients", "Mycophenolate Sodium therapy", "other immunosuppressive drugs" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1474, "imageuri": "https://productimages.withfloats.com/actual/6661a739c749b7962dbc08c6.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/6661a739c749b7962dbc08c6.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-06T12:10:30.488Z", "updatedon": "2026-03-12T08:02:36.733Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//mycophenolate-sodium-360-mg/1474", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "MYCOPLASM S 360 ", "category": "Oncology", "tags": [ "MYCOPLASM S 360", "Mycophenolate sodium (360mg)", "Mycophenolate sodium 360 mg price", "Mycophenolate sodium 360 mg brands", "Mycophenolate sodium 360 mg side effects", "Myfortic 360 alternative", "Myfortic 500" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6661a57d8da3a81d5c6a17dd", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Mycophenolate mofetil 500mg", "description": "MYCOPLASM M 500\nMycophenolate mofetil (500mg)\nMycoplasm M 500 is a medication containing Mycophenolate Mofetil in a 500mg dose. Mycophenolate Mofetil is an immunosuppressive drug used to prevent rejection in organ transplantation, particularly kidney, heart, and liver transplants. It works by inhibiting the proliferation of T and B lymphocytes, which are involved in the immune response that leads to rejection.\n\nThis medication is typically prescribed in combination with other immunosuppressants as part of a comprehensive transplant treatment regimen. It is important to take Mycoplasm M 500 exactly as prescribed by your healthcare provider to ensure optimal therapeutic outcomes and to minimize the risk of rejection or other complications.\n\nCommon side effects of Mycophenolate Mofetil may include gastrointestinal disturbances such as nausea, vomiting, diarrhea, and abdominal pain. It can also increase the risk of infections due to its immunosuppressive effects. Patients should be monitored regularly by their healthcare provider while taking this medication to assess for any potential adverse effects and to adjust the dosage as needed.\n\nMycoplasm M 500 should not be used in pregnant women or those planning to become pregnant without consulting a healthcare professional, as it can cause harm to the developing fetus. Additionally, it may interact with other medications, so it is important to inform your doctor about all the medications you are currently taking before starting Mycoplasm M 500 therapy.For further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nORDER Now: \n\n\n\n\nMycophenolate mofetil 500 mg stands as a cornerstone in modern immunosuppressive therapy, primarily designed to prevent organ transplant rejection in kidney, heart, and liver recipients. As a prodrug, it rapidly converts to its active form, mycophenolic acid (MPA), which selectively targets the proliferation of T and B lymphocytes—key players in immune responses that can attack transplanted organs. This medication, available in convenient 500 mg tablets, offers reliable protection against acute rejection episodes, making it an essential component in post-transplant regimens worldwide.​\n\nProduct Uses\nMycophenolate mofetil 500 mg finds its primary application in solid organ transplantation, where it helps maintain long-term graft survival. For kidney transplant patients, it is typically administered alongside corticosteroids and calcineurin inhibitors like cyclosporine or tacrolimus to suppress the immune system's overreaction to the new organ. In heart and liver transplants, it plays a similar role, reducing the incidence of rejection by inhibiting antibody production and cell-mediated immunity.​\n\nBeyond transplants, healthcare providers increasingly use mycophenolate mofetil 500 mg for various autoimmune conditions. It effectively manages lupus nephritis by curbing inflammation in the kidneys, showing superior efficacy over traditional therapies in preserving renal function. Rheumatoid arthritis patients benefit from its ability to dampen joint inflammation, while those with dermatomyositis or scleroderma experience reduced skin and muscle involvement. Off-label, it treats inflammatory bowel diseases like Crohn's disease and even certain skin disorders such as pemphigus vulgaris, where immune-mediated blistering threatens quality of life.​\n\nKey Benefits\nThe therapeutic advantages of mycophenolate mofetil 500 mg extend far beyond basic immunosuppression, offering patients enhanced outcomes and improved daily living.\n\nSuperior Graft Protection: Clinical data highlight reduced acute rejection rates by up to 50% when combined with standard regimens, leading to better long-term organ function and survival.​\n\nSelective Lymphocyte Targeting: By depleting guanosine nucleotides in T and B cells via inosine monophosphate dehydrogenase (IMPDH) inhibition, it spares other cell types, minimizing broad toxicity seen with older immunosuppressants.​\n\nAnti-Inflammatory Effects: MPA inhibits adhesion molecule glycosylation, preventing lymphocyte recruitment to inflamed sites, which alleviates symptoms in autoimmune flares.​\n\nOral Convenience: The 500 mg formulation allows flexible dosing—typically 1 gram twice daily—without the need for injections, improving patient adherence.​\n\nVersatility Across Conditions: Proven efficacy in lupus, vasculitis, and myositis expands its utility, often allowing steroid dose reduction and fewer relapses.​\n\nCardiovascular and Anticancer Potential: Emerging evidence suggests it delays graft atherosclerosis by reducing lipid oxidation and may hinder tumor progression in certain malignancies due to its impact on nucleotide synthesis.​\n\nThese benefits translate to fewer hospital readmissions, better quality of life, and cost savings in long-term care for transplant and autoimmune patients.​\n\nSide Effects\nWhile mycophenolate mofetil 500 mg provides robust immunosuppression, it carries risks typical of this drug class, necessitating vigilant monitoring.\n\nCommon side effects affect the gastrointestinal tract most prominently, with nausea, vomiting, diarrhea, and abdominal pain occurring in over 30% of users. These often improve with dose adjustments or enteric-coated alternatives, but hydration and antiemetics help manage them effectively.​\n\nHematologic issues like leukopenia, anemia, and thrombocytopenia arise due to bone marrow suppression, requiring regular complete blood counts—weekly initially, then monthly. Infections pose a significant threat, as suppressed immunity increases susceptibility to viral (e.g., CMV), bacterial, and fungal pathogens; prophylactic antivirals are standard.​\n\nLess frequent but notable effects include hypertension, tremor, insomnia, and elevated liver enzymes. Women face heightened risks of congenital malformations if used during pregnancy, mandating effective contraception and pregnancy testing. Rare severe reactions encompass progressive multifocal leukoencephalopathy (PML) from JC virus reactivation and hypersensitivity syndromes.​\n\nDosage and Administration Notes\nStandard dosing for renal transplants involves 1 gram (two 500 mg tablets) twice daily, starting within 72 hours post-surgery, with adjustments for renal impairment. Hepatic transplant patients may require higher initial doses due to metabolism differences. Always take on an empty stomach with water to optimize absorption, avoiding antacids that bind MPA.​\n\nPrecautions and Interactions\nPatients must avoid live vaccines, report fevers promptly, and undergo TB screening pre-treatment. Drug interactions with azathioprine, cholestyramine, or rifampin can alter levels, so pharmacists review regimens closely. Regular monitoring of MPA blood levels ensures therapeutic efficacy without toxicity.​\n\nConclusion\nMycophenolate mofetil 500 mg emerges as a transformative immunosuppressive agent, safeguarding transplanted organs and taming autoimmune storms with its precise mechanism of lymphocyte suppression and anti-inflammatory prowess. By delivering key benefits like reduced rejection, versatile applications, and manageable administration, it empowers patients to reclaim normalcy post-transplant or amid chronic illness. Despite potential side effects, proactive monitoring and personalized dosing mitigate risks, underscoring its value in contemporary medicine. For those navigating transplant recovery or autoimmune challenges, this medication offers hope and stability, backed by decades of clinical validation.\n\n", "price": 775.0, "discountamount": 256.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "part", "Call", "harm", "risk", "Email", "heart", "ORDER", "nausea", "kidney", "dosage", "doctor", "vomiting", "WhatsApp", "Patients", "diarrhea", "rejection", "infections", "500mg dose", "combination", "information", "sterisonline", "proliferation", "B lymphocytes", "abdominal pain", "pregnant women", "immune response", "developing fetus", "other medications", "liver transplants", "other complications", "healthcare provider", "Common side effects", "organ transplantation", "Mycophenolate mofetil", "immunosuppressive drug", "Mycoplasm M 500 therapy", "healthcare professional", "other immunosuppressants", "immunosuppressive effects", "potential adverse effects", "optimal therapeutic outcomes", "gastrointestinal disturbances", "comprehensive transplant treatment regimen" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1472, "imageuri": "https://productimages.withfloats.com/actual/6661a57fdd39d2ccddbc3bb9.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/6661a57fdd39d2ccddbc3bb9.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-06T12:03:09.216Z", "updatedon": "2026-03-12T08:00:39.14Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//mycophenolate-mofetil-500mg/1472", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "MYCOPLASM M 500", "category": "NEPHROLOGYRANGE", "tags": [ "MYCOPLASM M 500", "Mycophenolate mofetil (500mg)", "Mycophenolate mofetil 500 mg tablet", "Mycophenolate mofetil 500 mg price", "Mycophenolate mofetil 500 mg dosage", "Mycophenolate mofetil uses", "Mycophenolate mofetil side effects", "mycophenolate mofetil 500mg tablet uses", "mycophenolate mofetil 500mg dosage for kidney transplant", "mycophenolate mofetil 500mg for autoimmune disease" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "694004d8504825bb23fa3c1f", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Terbinafine and Itraconazole Tablets 250/100 mg", "description": "CONARIS T100 is a potent antifungal medication formulated with Terbinafine 250 mg and Itraconazole 100 mg. This combination tablet is designed to treat a wide range of fungal infections affecting the skin, nails, and other body parts. Terbinafine and Itraconazole work synergistically to eliminate fungi effectively by targeting their cell membranes and inhibiting growth, providing faster relief from symptoms such as itching, redness, scaling, and discomfort.\n\nFungal infections are common in humid climates and among individuals with compromised immunity, and medications like CONARIS T100 are essential for managing stubborn and recurrent infections. This combination therapy is often prescribed by dermatologists and healthcare professionals for moderate to severe fungal conditions.\n\nUses\n\nCONARIS T100 is used in the treatment of several fungal infections, including:\n\nDermatophytosis (Ringworm): Effective against infections of the skin, hair, and nails caused by dermatophytes.\n\nOnychomycosis (Nail Fungus): Helps in treating fungal infections of fingernails and toenails.\n\nTinea Infections: Treats tinea corporis, tinea cruris, and tinea pedis (athlete’s foot).\n\nCandidiasis: Useful in managing Candida infections affecting the skin and mucous membranes.\n\nRecurrent or Resistant Fungal Infections: Provides stronger antifungal action in cases not responsive to monotherapy.\n\nBenefits\n1. Broad-Spectrum Antifungal Action\n\nThe combination of Terbinafine and Itraconazole ensures effective activity against a wide variety of fungal species, including dermatophytes and yeasts.\n\n2. Faster Symptom Relief\n\nBy targeting fungi at multiple levels, CONARIS T100 helps relieve itching, redness, scaling, and discomfort more quickly than single-agent therapy.\n\n3. Treats Nail and Skin Infections\n\nTerbinafine penetrates nails effectively, while Itraconazole enhances the antifungal spectrum, making the combination ideal for nail and skin fungal infections.\n\n4. Reduces Recurrence\n\nCombination therapy decreases the risk of fungal infections returning by ensuring complete eradication of the pathogen.\n\n5. Convenient Dosage Form\n\nAvailable as an oral tablet, making it easy to administer and suitable for long-term treatment if prescribed.\n\nDosage\n\nAdults: Usually, one tablet of CONARIS T100 daily, preferably after meals, or as directed by a healthcare professional.\n\nTreatment Duration: Varies depending on the type and severity of infection; may range from 2 to 12 weeks for skin infections and longer for nail infections.\n\nImportant: Do not self-adjust dosage or stop treatment prematurely, as incomplete therapy can lead to recurrence or resistance.\n\nSide Effects\n\nCONARIS T100 is generally well tolerated when used as prescribed. Mild side effects may include:\n\nNausea or vomiting\n\nStomach upset or diarrhea\n\nHeadache\n\nDizziness\n\nSerious Side Effects (Rare)\n\nLiver enzyme elevation (monitoring recommended for long-term use)\n\nAllergic reactions such as rash, itching, or swelling\n\nSevere gastrointestinal discomfort\n\nConsult a healthcare provider immediately if you experience jaundice, persistent fatigue, or severe allergic reactions.\n\nPrecautions and Warning\n\nPregnancy and Breastfeeding: Use only if prescribed by a doctor; safety during pregnancy is not fully established.\n\nLiver or Kidney Disorders: Dose adjustment or close monitoring may be required.\n\nDrug Interactions: Inform your doctor about all medications, especially antifungals, statins, or anticoagulants.\n\nAvoid Self-Medication: Fungal infections may mimic other skin conditions, so proper diagnosis is essential.\n\nAlcohol Consumption: Avoid alcohol as it may increase liver toxicity risk.\n\nStorage: Store in a cool, dry place away from direct sunlight and out of children’s reach.\n\nConclusion\n\nCONARIS T100, containing Terbinafine 250 mg and Itraconazole 100 mg, is a reliable and effective treatment for a wide spectrum of fungal infections, including skin, nail, and mucosal infections. Its dual-action antifungal mechanism provides faster symptom relief, reduces recurrence, and improves overall patient outcomes.\n\nWhen used under medical supervision and following prescribed dosage, CONARIS T100 offers a safe and convenient option for managing both common and stubborn fungal infections, ensuring better skin and nail health and enhanced quality of life.", "price": 184.0, "discountamount": 55.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2248, "imageuri": "https://productimages.withfloats.com/actual/694004da351fe1d6b98476e6.png", "tileimageuri": "https://productimages.withfloats.com/tile/694004da351fe1d6b98476e6.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-15T12:53:44.573Z", "updatedon": "2026-03-12T07:12:53.163Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//terbinafine-and-itraconazole-tablets-250-100-mg/2248", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "CONARIS T100", "category": "DERMATALOGY", "tags": [ "terbinafine and itraconazole tablets", "terbinafine and itraconazole together", "terbinafine and itraconazole tablets uses", "terbinafine and itraconazole for nail fungus", "terbinafine and itraconazole tablets uses", "terbinafine itraconazole combination tablet", "terbinafine itraconazole tablets for fungal infection", "terbinafine itraconazole tablets composition", "terbinafine and itraconazole tablets dosage", "terbinafine itraconazole tablets price in india", "terbinafine itraconazole tablets brand name", "terbinafine and itraconazole tablets for ringworm", "terbinafine itraconazole tablets for skin fungal infection", "terbinafine itraconazole tablets for tinea infection", "terbinafine itraconazole tablets for nail fungus", "terbinafine itraconazole tablets how to use", "terbinafine itraconazole tablets side effects", "terbinafine itraconazole tablets benefits", "terbinafine itraconazole tablets working mechanism", "terbinafine itraconazole tablets manufacturer in india", "terbinafine itraconazole tablets supplier", "terbinafine itraconazole tablets wholesale", "terbinafine itraconazole tablets pcd pharma" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "69400387893a9153e4bd58a8", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Terbinafine and Itraconazole Tablets 250/200mg", "description": "CONARIS T200 is a potent antifungal combination tablet containing Terbinafine 250 mg and Itraconazole 200 mg, formulated to provide effective treatment for various fungal infections. Fungal infections of the skin, nails, and hair are common in India due to the hot and humid climate. These infections can cause itching, redness, scaling, and discomfort, affecting daily life and confidence.\n\nBy combining two powerful antifungal agents, CONARIS T200 targets fungal infections effectively, providing faster relief and improved recovery compared to monotherapy. Terbinafine works by inhibiting fungal cell growth, while Itraconazole disrupts fungal cell membrane formation, resulting in a comprehensive antifungal effect.\n\nUses\n\nCONARIS T200 is primarily prescribed for the management of:\n\nDermatophytosis (Ringworm, Tinea Infections)\nTreats fungal infections affecting skin, nails, and scalp.\n\nOnychomycosis (Fungal Nail Infection)\nHelps in eliminating nail fungus and promotes healthy nail growth.\n\nCandidiasis (Yeast Infections)\nEffective against mucocutaneous and superficial candidal infections.\n\nOther Superficial Fungal Infections\nUseful in treating skin infections caused by dermatophytes, yeasts, and other fungi.\n\nThis combination is particularly beneficial for chronic, resistant, or recurrent fungal infections.\n\nBenefits\n1. Broad-Spectrum Antifungal Activity\n\nThe dual action of Terbinafine and Itraconazole ensures effectiveness against a wide range of fungi, providing comprehensive treatment.\n\n2. Faster Symptom Relief\n\nPatients experience reduced itching, redness, scaling, and discomfort sooner than with single antifungal therapy.\n\n3. Promotes Healing\n\nSupports the restoration of healthy skin and nails, improving appearance and comfort.\n\n4. Reduces Recurrence\n\nThe combination therapy helps prevent fungal infections from returning, especially in chronic or resistant cases.\n\n5. Convenient Oral Administration\n\nOnce- or twice-daily tablet dosing improves patient compliance compared to topical treatments.\n\n6. Suitable for Adults\n\nFormulated for adult patients suffering from persistent fungal infections that require systemic therapy.\n\nDosage\n\nThe recommended dose of CONARIS T200 is usually one tablet once daily, or as directed by a physician.\n\nDuration of therapy depends on the type and severity of infection:\n\nSkin infections: Typically 2–4 weeks\n\nNail infections: May require 6–12 weeks or longer for full recovery\n\nImportant Instructions:\n\nSwallow the tablet whole with water.\n\nTake the medicine after food to reduce stomach upset.\n\nDo not skip doses and complete the full course even if symptoms improve.\n\nAlways follow the prescribing doctor’s instructions to ensure optimal results.\n\nSide Effects\n\nCONARIS T200 is generally well-tolerated, but some patients may experience mild side effects:\n\nNausea and vomiting\n\nStomach discomfort or indigestion\n\nHeadache\n\nDizziness\n\nSerious but Rare Side Effects\n\nLiver function disturbances\n\nAllergic reactions such as rash or swelling\n\nSevere gastrointestinal discomfort\n\nIf any unusual or severe symptoms appear, consult a healthcare professional immediately.\n\nPrecautions and Warning\n\nLiver and Kidney Disorders: Use with caution; liver function tests may be recommended during therapy.\n\nPregnancy and Breastfeeding: Consult your doctor before use; safety has not been fully established.\n\nDrug Interactions: Inform your doctor about other medications, particularly antacids, anticoagulants, or statins.\n\nAllergy: Avoid if allergic to Terbinafine, Itraconazole, or any other ingredient in the tablet.\n\nAlcohol Consumption: Limit alcohol intake, as it may increase the risk of liver-related side effects.\n\nConclusion\n\nCONARIS T200 (Terbinafine 250 mg + Itraconazole 200 mg) is an effective and trusted antifungal combination for the treatment of a variety of superficial and chronic fungal infections. By targeting fungi through dual mechanisms, it provides faster relief, promotes healing, and helps prevent recurrence. With proper dosing, adherence to medical advice, and monitoring for side effects, CONARIS T200 offers a comprehensive solution for adults dealing with persistent fungal infections, helping restore healthy skin, nails, and overall comfort.", "price": 204.0, "discountamount": 61.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2247, "imageuri": "https://productimages.withfloats.com/actual/69400389f34633ae3de3f8f4.png", "tileimageuri": "https://productimages.withfloats.com/tile/69400389f34633ae3de3f8f4.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-15T12:48:07.707Z", "updatedon": "2026-03-12T07:12:03.519Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//terbinafine-and-itraconazole-tablets-250-200mg/2247", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "CONARIS T200", "category": "DERMATALOGY", "tags": [ "terbinafine and itraconazole tablets", "terbinafine and itraconazole", "terbinafine and itraconazole combination", "terbinafine and itraconazole together", "Fungal infections of the skin", "helping restore healthy skin" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "69316145bf2a5ce08905eadf", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Temozolomide 250 mg", "description": "Temozolomide 250 mg, marketed under the brand name TMOZOLMIDE 250 by Steris Healthcare, is a potent chemotherapy drug primarily used to treat certain aggressive brain tumors such as glioblastoma multiforme (GBM) and anaplastic astrocytoma. Its mechanism of action involves alkylation of DNA, which damages the cancer cells’ DNA strands, leading to their programmed death and inhibition of tumor growth. This effect is achieved through the addition of a methyl group at the O6 and N7 positions of guanine in DNA. Tumor cells damaged by this process are unable to reproduce and eventually die, making Temozolomide an effective agent in chemotherapy regimens[,].​\n\nWhat are the benefits of temozolomide 250 mg?\nTemozolomide 250 mg offers significant benefits for patients battling brain cancers. It crosses the blood-brain barrier effectively, which allows it to reach tumor cells inside the brain where many other drugs cannot penetrate. This expands its efficacy in treating primary brain tumors and certain metastatic tumors that have spread to the brain. In clinical settings, it has been shown to improve progression-free survival rates and, in some cases, overall survival when used with radiation therapy or alone during maintenance treatment phases[,].​\n\nKey Benefits of Temozolomide 250 mg\nEffective treatment of aggressive brain tumors like glioblastoma multiforme and anaplastic astrocytoma.\n\nCan be administered orally, offering convenience compared to intravenous chemotherapy.\n\nAbility to cross the blood-brain barrier, ensuring targeted therapy within the central nervous system.\n\nWell-established as part of the standard Stupp protocol (combined with radiotherapy).\n\nMay improve quality of life by slowing tumor progression and managing symptoms associated with brain tumors[,].​\n\nSide Effects of Temozolomide 250 mg\nWhile Temozolomide is effective, it may cause side effects common to chemotherapy medications due to its impact on both cancerous and healthy rapidly dividing cells.\n\nCommon Side Effects of Temozolomide 250 mg\nNausea and vomiting, which can sometimes be severe.\n\nFatigue and weakness.\n\nHair thinning or hair loss.\n\nConstipation or diarrhea.\n\nLoss of appetite.\n\nMouth sores or changes in taste.\n\nDizziness or headache.\n\nMild skin rashes or itching[,].​\n\nSerious Side Effects of Temozolomide 250 mg\nSignificant reduction in blood cell counts causing anemia, leukopenia, or thrombocytopenia (requiring close blood monitoring).\n\nSevere infections due to immune suppression.\n\nAllergic reactions, including swelling, itching, or rash.\n\nLiver dysfunction or jaundice.\n\nSeizures or neurological symptoms.\n\nUnusual bleeding or bruising.\n\nSigns of severe allergic reaction like difficulty breathing[,].​\n\nAvailable Substitute for Temozolomide 250 mg\nThere are limited direct substitutes for Temozolomide due to its unique ability to treat brain tumors crossing the blood-brain barrier. Alternatives depend on tumor type and may include other chemotherapy drugs like lomustine (CCNU), carmustine (BCNU), or newer targeted therapies and immunotherapies under clinical trial. However, these alternatives may vary in efficacy and side effect profile and are generally used under oncologist guidance[,].\n\nDosage Guidelines for Temozolomide 250 mg\nThe dosage of Temozolomide 250 mg (TMOZOLMIDE 250) by Steris Healthcare is carefully tailored based on the type and stage of cancer, body surface area (BSA), and patient tolerance. The standard regimen for newly diagnosed glioblastoma is an oral dose of 75 mg/m² daily during radiotherapy, followed by maintenance cycles of 150 to 200 mg/m² for 5 days every 28 days. Dose adjustments are common based on blood counts and side effects. Strict adherence to the prescribed dosage schedule and monitoring are critical for safety and efficacy.", "price": 12187.0, "discountamount": 3657.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2229, "imageuri": "https://productimages.withfloats.com/actual/693161477743cf6a1359d094.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/693161477743cf6a1359d094.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-04T10:24:05.165Z", "updatedon": "2026-03-12T08:08:17.975Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//temozolomide-250-mg/2229", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TMOZOLMIDE 250", "category": "Oncology", "tags": [ "Temozolomide 250 mg", "cancer", "brain tumors", "cancer cells", "Tumor cells", "chemotherapy", "TMOZOLMIDE 250", "Temozolomide 250 mg capsule uses", "How to take Temozolomide 250 mg correctly", "Temozolomide 250 mg dosage schedule guide", "Temozolomide 250 mg dosage schedule guide", "Temozolomide 250 mg for glioblastoma treatment", "Temozolomide 250 mg empty stomach instructions", "What is Temozolomide 250 mg prescribed for", "Temozolomide 250 mg chemotherapy cycle details", "Temozolomide 250 mg patient information leaflet", "Temozolomide 250 mg storage instructions", "Temozolomide 250 mg manufacturer price" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68fcc29bc16e985630575201", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Activated Dimethicone IP 50 mg, Magnesium Hydroxide IP 250 mg, Dried Aluminium Hydroxide Gel IP 250 mg & Magnesium Aluminium Silicate Hydrate 50 mg", "description": "Heartburn MPS Chewable Tablets are a fast-acting, reliable solution for relieving acidity, heartburn, bloating, and gas. Formulated with a combination of antacid and antiflatulent ingredients, Heartburn MPS provides quick and soothing relief from digestive discomfort caused by acid reflux, indigestion, or excessive gas formation.\nComposition (Each Uncoated Chewable Tablet Contains):\nActivated Dimethicone I.P. – 50 mg\nHelps reduce gas and bloating by breaking down gas bubbles in the stomach and intestines.\nMagnesium Hydroxide I.P. – 250 mg\nNeutralizes excess stomach acid and relieves symptoms of acidity and indigestion.\nDried Aluminium Hydroxide Gel I.P. – 250 mg\nProvides rapid acid neutralization and offers a soothing protective coating on the stomach lining.\nMagnesium Aluminium Silicate Hydrate – 50 mg\nActs as a stabilizer and enhances the consistency and effectiveness of the antacid formulation.\nColours:\nMint Tablet: Erythrosine & Ponceau 4R\nOrange Tablet: Sunset Yellow FCF\nMixed Fruit Tablet: Quinoline Yellow WS & Sunset Yellow FCF\nIndications / Uses\nHeartburn MPS Chewable Tablets are indicated for the symptomatic relief of:\nHeartburn and Acidity\nGas and Bloating\nIndigestion and Sour Stomach\nGastric Discomfort and Flatulence\nIt can be taken whenever symptoms of acidity or gas are pronounced, especially after meals.\nMechanism of Action:\nThe combination of Magnesium Hydroxide and Aluminium Hydroxide works by neutralizing stomach acid, thus reducing the burning sensation and discomfort caused by acid reflux.\nMeanwhile, Activated Dimethicone helps relieve bloating and abdominal fullness by dispersing trapped gas. This synergistic action provides quick, long-lasting comfort.\nDosage & Administration:\nRecommended Dose:\n1 to 2 tablets to be chewed ½ to 1 hour after meals or whenever symptoms occur.\nDo not take more than 10 tablets in 24 hours.\nDo not exceed the recommended dose or use the medication for more than two weeks without consulting a physician.\nStorage Instructions:\nStore in a cool, dry, and dark place at a temperature not exceeding 30°C.\nKeep out of reach of children.\nProtect from light and moisture.\nSafety & Precautions:\nKidney Patients: Those with kidney disease should use this medication only under medical supervision.\nLong-Term Use: Prolonged or excessive use may alter electrolyte balance; consult a doctor if symptoms persist.\nPregnancy & Lactation: Use under medical advice.\nPossible Side Effects:\nHeartburn MPS is generally well tolerated. However, some users may experience mild:\nConstipation or Diarrhea\nStomach Cramps\nNausea (rare)\nIf any of these persist or worsen, seek medical attention promptly.\nKey Benefits of Heartburn MPS:\n Instant Relief: Rapid action against acidity and gas discomfort.\n Dual Action Formula: Combines antacid and antiflatulent properties.\n Pleasant Flavors: Available in Mint, Orange, and Mixed Fruit variants.\n Convenient Chewable Form: No water needed; easy to use anywhere.\n Safe & Effective: Manufactured under ISO 9001:2015 & WHO-GMP Certified facilities.\n\nManufacturer Information:\nManufactured by:\nLucent Biotech Limited (Unit-II)\n(An ISO 9001:2015 & WHO GMP certified company)\n165/3, Nalhera-Amanpur, Roorkee-247667,\nDist. Haridwar, Uttarakhand, India.\n\nWhy Choose Heartburn MPS?\nHeartburn MPS stands out as a trusted, fast-acting antacid solution that provides reliable relief from acidity and gas. It’s manufactured under stringent pharmaceutical standards, ensuring quality, safety, and consistent effectiveness in every tablet. Whether it’s a post-meal burning sensation or bloating discomfort, Heartburn MPS delivers gentle yet powerful relief whenever you need it.", "price": 49.0, "discountamount": 14.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2192, "imageuri": "https://productimages.withfloats.com/actual/68fcc29dc406e09587e138d1.png", "tileimageuri": "https://productimages.withfloats.com/tile/68fcc29dc406e09587e138d1.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-10-25T12:29:15.393Z", "updatedon": "2026-03-14T08:00:58.498Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//activated-dimethicone-ip-50-mg-magnesium-hydroxide-ip-250-mg-dried-aluminium-hydroxide-gel-ip-250-mg-magnesium-aluminium-silicate-hydrate-50-mg/2192", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "HEARTBURN MPS", "category": "GENERAL RANGE", "tags": [ "Gas and Bloating", "Heartburn and Acidity", "Heartburn MPS Chewable Tablets", "heartburn", "bloating", "gas." ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68b6d7adf76d65ff43c4825b", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Phenoxymethylpenicillin Potassium 250 mg", "description": "Description: \nPENITRIAD 250 contains Phenoxymethylpenicillin Potassium 250 mg, a trusted antibiotic from the penicillin group. It is widely used to treat a variety of bacterial infections by stopping the growth of harmful bacteria in the body. Known for its effectiveness and safety, this medicine has been prescribed for decades in both adults and children for conditions like throat infections, ear infections, skin infections, and respiratory tract infections.\n\n \nWhat is PENITRIAD 250?\n \n\nPENITRIAD 250 is an oral antibiotic formulation of Phenoxymethylpenicillin Potassium 250 mg, also called Penicillin V potassium. It belongs to the beta-lactam class of antibiotics, which work by interfering with the bacterial cell wall, ultimately killing the bacteria and preventing further spread of infection.\n\nUnlike some broad-spectrum antibiotics, PENITRIAD 250 is specifically effective against certain bacteria, making it a reliable treatment option for mild to moderately severe infections when used under medical guidance.\n\n \nUses of PENITRIAD 250\n \n\nPENITRIAD 250 is used for the treatment and prevention of:\n\nThroat and Tonsil Infections – including streptococcal pharyngitis (strep throat)\n\nEar Infections – such as otitis media and otitis externa\n\nSkin and Soft Tissue Infections – boils, cellulitis, erysipelas, and wound infections\n\nRespiratory Tract Infections – bronchitis, pneumonia, and other bacterial chest infections\n\nDental Infections – helps prevent and treat bacterial spread after dental procedures\n\nProphylaxis of Rheumatic Fever – prevention of recurrence in susceptible individuals\n\n \nBenefits of PENITRIAD 250\n \n\nTrusted penicillin-based antibiotic with a long history of safety\n\nEffective against streptococcal and staphylococcal infections\n\nWell-suited for children and adults in appropriate doses\n\nAvailable in convenient oral tablet form\n\nPlays a key role in preventing rheumatic fever complications\n\n \nPossible Side Effects of PENITRIAD 250\n \n\nLike all antibiotics, PENITRIAD 250 may cause some side effects, although not everyone experiences them. Common ones include:\n\nNausea, vomiting, or diarrhea\n\nStomach pain or discomfort\n\nSkin rash or itching\n\nMild allergic reactions\n\nIn rare cases, severe allergic reactions such as anaphylaxis can occur. If you notice swelling, difficulty breathing, or severe rash, seek medical attention immediately.\n\n \nPrecautions Before Using PENITRIAD 250\n \n\nInform your doctor if you have a history of penicillin allergy or hypersensitivity\n\nPatients with kidney problems should use this medicine cautiously\n\nNot recommended for viral infections such as cold or flu\n\nPregnant and breastfeeding women should consult their doctor before use\n\nComplete the full prescribed course, even if symptoms improve early, to prevent antibiotic resistance\n\n \nDrug Interactions\n \n\nPENITRIAD 250 may interact with certain medicines, including:\n\nMethotrexate – increases the risk of toxicity\n\nOral contraceptives – effectiveness may be reduced\n\nOther antibiotics such as tetracyclines – may reduce its antibacterial effect\n\nBlood-thinning agents (warfarin) – increased risk of bleeding\n\nAlways inform your healthcare provider about all medicines, supplements, or herbal remedies being taken to avoid complications.\n\n \nConclusion\n \n\nPENITRIAD 250 – Phenoxymethylpenicillin Potassium 250 mg is a time-tested antibiotic that offers reliable treatment for a variety of bacterial infections. By targeting and eliminating harmful bacteria, it helps patients recover faster and prevents complications like rheumatic fever.\n\nWhen taken as prescribed and with proper medical guidance, PENITRIAD 250 provides effective relief from infections, improves patient outcomes, and promotes long-term health.", "price": 58.0, "discountamount": 17.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2171, "imageuri": "https://productimages.withfloats.com/actual/68b6d7b16d38e6f9fa86bcb6.png", "tileimageuri": "https://productimages.withfloats.com/tile/68b6d7b16d38e6f9fa86bcb6.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-09-02T11:40:29.835Z", "updatedon": "2026-03-14T05:47:14.657Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//phenoxymethylpenicillin-potassium-250-mg/2171", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "PENITRIAD 250", "category": "GENERAL RANGE", "tags": [ "phenoxymethylpenicillin potassium tablets uses", "phenoxymethylpenicillin potassium tablets ip 250 mg", "phenoxymethylpenicillin potassium tablets", "phenoxymethylpenicillin potassium side effects.", "phenoxymethylpenicillin potassium tablets 250mg", "buy phenoxymethylpenicillin potassium tablets online", "phenoxymethylpenicillin potassium tablets price", "phenoxymethylpenicillin potassium tablets for skin infection", "what is phenoxymethylpenicillin potassium 250mg used for" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "67c98ea29006a7b5368cb903", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Sucroferric Oxyhydroxide 2500 mg", "description": "RUDIX SUCRO FE contains Sucroferric Oxyhydroxide (2500 mg), a highly effective phosphate binder used in the management of chronic kidney disease (CKD) patients undergoing dialysis. It helps control high phosphate levels (hyperphosphatemia) in the blood, reducing the risk of bone disorders, cardiovascular complications, and other phosphate-related issues. Its iron-based composition ensures efficient phosphate binding while minimizing gastrointestinal side effects.\n\n \nKey Benefits:\n \n\n Effectively Lowers Phosphate Levels – Reduces phosphate absorption in CKD patients on dialysis.\n Prevents Bone & Heart Complications – Protects against renal osteodystrophy and vascular calcification.\n Iron-Based, Non-Calcium Formula – Minimizes the risk of hypercalcemia and calcium overload.\n Fast-Acting & Well-Tolerated – Begins working quickly and causes fewer gastrointestinal issues compared to other phosphate binders.\n Convenient Dosage & Administration – Requires fewer tablets per day, enhancing patient adherence.\n Supports Overall Kidney Health – Helps manage phosphorus balance, improving long-term health outcomes in CKD patients.\n\n \nHow Does It Work?\n \n\nSucroferric Oxyhydroxide acts as a phosphate binder, meaning it binds to dietary phosphate in the intestines and prevents its absorption into the bloodstream. Instead, the bound phosphate is excreted through the stool, effectively lowering serum phosphate levels. This helps protect the bones, heart, and blood vessels from damage caused by excess phosphorus accumulation.\n\n \nDirections for Use:\n \n\nTake as prescribed by a healthcare professional.\nThe usual recommended dose is 1 tablet with each meal, but the dose may be adjusted based on phosphate levels.\nSwallow the tablet whole or chew it before swallowing.\nAvoid taking it with other medications, as it may interfere with their absorption.\nRegular monitoring of phosphate levels is essential to adjust the dosage accordingly.\n \nSide Effects:\n \n\nWhile RUDIX SUCRO FE is generally well-tolerated, some possible side effects include:\n\nMild gastrointestinal issues (diarrhea, nausea, constipation)\nDark-colored stools due to iron content (this is harmless)\nMetallic taste or changes in taste perception\nRare allergic reactions (rash, itching, swelling)\nIf severe symptoms such as persistent stomach pain, vomiting, or difficulty breathing occur, seek immediate medical attention.", "price": 320.0, "discountamount": 96.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "1 tablet", "medical attention", "severe symptoms", "iron content", "generally welltolerated", "side effects", "adjusted based", "healthcare professional", "damage caused", "blood vessels", "bones heart", "helps protect", "renal osteodystrophy", "ckd patients", "phosphaterelated issues", "blood reducing", "bound phosphate", "dietary phosphate", "phosphate levels", "phosphate levels swallow", "absorption regular monitoring", "usual recommended dose", "phosphate binder meaning", "harmless metallic taste", "rudix sucro fe", "swallowing avoid taking" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2066, "imageuri": "https://productimages.withfloats.com/actual/67c98ec0bf545f60b10e551d.png", "tileimageuri": "https://productimages.withfloats.com/tile/67c98ec0bf545f60b10e551d.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-03-06T12:01:38.223Z", "updatedon": "2026-03-12T12:13:45.487Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//sucroferric-oxyhydroxide-2500-mg/2066", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Steris Healthcare Pvt Ltd", "category": "NEPHROLOGYRANGE", "tags": [ "Sucroferric oxyhydroxide tablet chewable 500 mg", "Sucroferric Oxyhydroxide chewable tablets uses in hindi" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }